Published in Mediators Inflamm on December 13, 2012
Critical role of TNF-α in cerebral aneurysm formation and progression to rupture. J Neuroinflammation (2014) 1.15
Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe? BMC Neurosci (2014) 1.00
The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res (2013) 0.99
Inflammation, vasospasm, and brain injury after subarachnoid hemorrhage. Biomed Res Int (2014) 0.90
Localized increase of chemokines in the lumen of human cerebral aneurysms. Stroke (2013) 0.90
Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One (2013) 0.88
The association between meteorological parameters and aneurysmal subarachnoid hemorrhage: a nationwide analysis. PLoS One (2014) 0.86
Potential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis (2015) 0.85
Lung deposition analyses of inhaled toxic aerosols in conventional and less harmful cigarette smoke: a review. Int J Environ Res Public Health (2013) 0.81
Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products. Fluids Barriers CNS (2015) 0.78
Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms. Hypertension (2014) 0.78
Delivery of Polymeric Nanoparticles to Target Vascular Diseases. J Biomol Res Ther (2014) 0.77
Body pigmentation as a risk factor for the formation of intracranial aneurysms. Biomed Res Int (2014) 0.76
Differential Cerebrovascular Toxicity of Various Tobacco Products: A Regulatory Perspective. J Pharmacovigil (2015) 0.76
Distribution of ABO blood groups in the patients with intracranial aneurysm and association of different risk factors with particular blood type. Asian J Neurosurg (2015) 0.75
Evidence That a Subset of Aneurysms Less Than 7 mm Warrant Treatment. J Am Heart Assoc (2016) 0.75
Long-term patency of superficial temporal artery to middle cerebral artery bypass for cerebral atherosclerotic disease: factors determining the bypass patent. Neurosurg Rev (2016) 0.75
Identification of the miRNA-target gene regulatory network in intracranial aneurysm based on microarray expression data. Exp Ther Med (2017) 0.75
The efficacy of microsurgery in the treatment of cerebral aneurysm rupture and its effect on NF-κB, MCP-1 and MMP-9. Exp Ther Med (2017) 0.75
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev (2004) 16.52
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res (2000) 10.95
Passive smoking and heart disease. Epidemiology, physiology, and biochemistry. Circulation (1991) 7.94
The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol (2004) 6.44
Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol (2004) 5.34
Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke (1998) 4.12
Passive smoking as well as active smoking increases the risk of acute stroke. Tob Control (1999) 3.91
Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann N Y Acad Sci (1993) 3.80
Role of oxidative stress in atherosclerosis. Am J Cardiol (2003) 3.66
Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol (2009) 3.66
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Prog Cardiovasc Dis (2003) 2.75
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res (2007) 2.55
Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: histological analysis of 24 unruptured and 42 ruptured cases. Stroke (2004) 2.53
Are aortic aneurysms caused by atherosclerosis? Circulation (1992) 2.52
Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase. Circ Res (2000) 2.52
Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart (1997) 2.50
Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun (2009) 2.49
Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke (2005) 2.41
Structural fragility and inflammatory response of ruptured cerebral aneurysms. A comparative study between ruptured and unruptured cerebral aneurysms. Stroke (1999) 2.10
Enzymatic function of nitric oxide synthases. Cardiovasc Res (1999) 2.10
Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh Artery Study. Eur Heart J (1999) 2.08
Trigger factors and their attributable risk for rupture of intracranial aneurysms: a case-crossover study. Stroke (2011) 1.96
Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol (1997) 1.90
Critical roles of macrophages in the formation of intracranial aneurysm. Stroke (2010) 1.85
Intracranial aneurysms: links among inflammation, hemodynamics and vascular remodeling. Neurol Res (2006) 1.81
Hazardous compounds in tobacco smoke. Int J Environ Res Public Health (2011) 1.75
Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol (2002) 1.73
Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation (1996) 1.67
Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis (2002) 1.63
Arterial enlargement in response to high flow requires early expression of matrix metalloproteinases to degrade extracellular matrix. Exp Mol Pathol (2002) 1.62
Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke (2006) 1.56
Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation (2009) 1.52
Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor. J Surg Res (2007) 1.51
Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation (2000) 1.50
Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension (2005) 1.49
The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg (2005) 1.49
Endothelial cells require STAT3 for protection against endotoxin-induced inflammation. J Exp Med (2003) 1.49
Kruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids. Am J Physiol Cell Physiol (2008) 1.46
Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke (2009) 1.45
Platelet-derived growth factor-BB represses smooth muscle cell marker genes via changes in binding of MKL factors and histone deacetylases to their promoters. Am J Physiol Cell Physiol (2006) 1.44
Genomewide-linkage and haplotype-association studies map intracranial aneurysm to chromosome 7q11. Am J Hum Genet (2001) 1.43
Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation (2003) 1.42
The critical role of hemodynamics in the development of cerebral vascular disease. J Neurosurg (2010) 1.40
Platelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes. Am J Physiol Heart Circ Physiol (2004) 1.40
NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation (2007) 1.39
Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery (1997) 1.36
PGE(2) -EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB. Br J Pharmacol (2011) 1.34
TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag (2008) 1.31
Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol (2010) 1.29
Genetics of intracranial aneurysms. Neurosurgery (2007) 1.27
Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci (2005) 1.25
Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery (2005) 1.20
Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats. J Neurosurg (2007) 1.17
Immunocytochemical studies of atherosclerotic lesions of cerebral berry aneurysms. J Neuropathol Exp Neurol (1994) 1.16
Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med (1998) 1.16
Inflammatory changes in the aneurysm wall: a review. J Neurointerv Surg (2010) 1.13
Endothelial STAT3 plays a critical role in generalized myocardial proinflammatory and proapoptotic signaling. Am J Physiol Heart Circ Physiol (2007) 1.11
Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol (2006) 1.11
Pathophysiological impact of cigarette smoke exposure on the cerebrovascular system with a focus on the blood-brain barrier: expanding the awareness of smoking toxicity in an underappreciated area. Int J Environ Res Public Health (2010) 1.11
Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke (2007) 1.10
Mechanisms underlying cerebrovascular effects of cigarette smoking in rats in vivo. Stroke (1998) 1.10
Effects of tobacco smoke on the secretion of interleukin-1beta, tumor necrosis factor-alpha, and transforming growth factor-beta from peripheral blood mononuclear cells. Oral Microbiol Immunol (2002) 1.10
Nicotine and cotinine modulate cerebral microvascular permeability and protein expression of ZO-1 through nicotinic acetylcholine receptors expressed on brain endothelial cells. J Pharm Sci (2002) 1.09
Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. Proc Natl Acad Sci U S A (2011) 1.08
Progressive aneurysm development following hemodynamic insult. J Neurosurg (2010) 1.07
Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm. Surg Neurol (2007) 1.07
Gene expression profiles in human ruptured and unruptured intracranial aneurysms: what is the role of inflammation? Stroke (2009) 1.05
Interleukin-1β modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-κB-dependent mechanisms. Physiol Genomics (2012) 1.04
Review of current theories for abdominal aortic aneurysm pathogenesis. Vascular (2009) 1.04
Active and passive smoking and the risk of subarachnoid hemorrhage: an international population-based case-control study. Stroke (2004) 1.03
Cigarette suppresses the expression of P4Halpha and vascular collagen production. Biochem Biophys Res Commun (2004) 1.02
Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls. Neurosurgery (2005) 1.01
Tobacco smoke: a critical etiological factor for vascular impairment at the blood-brain barrier. Brain Res (2009) 1.01
The relationship between smoking and replicated sequence variants on chromosomes 8 and 9 with familial intracranial aneurysm. Stroke (2010) 1.01
Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers. Circulation (2003) 1.00
Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats. J Hypertens (2010) 1.00
Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice. Lab Invest (2009) 0.98
Characteristics of intracranial aneurysms in patients with familial subarachnoid hemorrhage. Neurology (2004) 0.98
Contribution of mast cells to cerebral aneurysm formation. Curr Neurovasc Res (2010) 0.97
Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts. Arterioscler Thromb Vasc Biol (2003) 0.97
Nicotine induces mitogen-activated protein kinase dependent vascular smooth muscle cell migration. Atherosclerosis (2005) 0.96
Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling. Toxicol Sci (2011) 0.96
Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke (2006) 0.96
Effect of spatial gradient in fluid shear stress on morphological changes in endothelial cells in response to flow. Biochem Biophys Res Commun (2010) 0.96
Nitric oxide-mediated blood flow regulation as affected by smoking and nicotine. Eur J Pharmacol (2010) 0.96
Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 0.95
Are cerebral aneurysms atherosclerotic? Stroke (1994) 0.95
Interactions of exogenous or evoked agents and particles: the role of reactive oxygen species. Free Radic Biol Med (2003) 0.95
MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage. J Neurol Sci (2006) 0.95
Management of incidentally discovered intracranial vascular abnormalities. Neurosurg Focus (2011) 0.94
Interactions between cultured bovine arterial endothelial and smooth muscle cells: effects of injury on the release of growth stimulating and growth inhibiting substances. Pharmacol Toxicol (1991) 0.94
Effect of fluid shear stress on migration of vascular smooth muscle cells in cocultured model. Ann Biomed Eng (2006) 0.93
Histological analysis of clipped human intracranial aneurysms and parent arteries with short-term follow-up. Cardiovasc Pathol (2011) 0.93
Chronic nicotine alters NO signaling of Ca(2+) channels in cerebral arterioles. Circ Res (2001) 0.92
The genetics of sporadic ruptured and unruptured intracranial aneurysms: a genetic meta-analysis of 8 genes and 13 polymorphisms in approximately 20,000 individuals. J Neurosurg (2010) 0.92
Seven-transmembrane-spanning receptors and heart function. Nature (2002) 5.38
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med (2008) 3.98
Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress. Circulation (2002) 3.15
A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse. Circ Res (2010) 3.00
Radiosurgery for patients with unruptured intracranial arteriovenous malformations. J Neurosurg (2013) 2.93
A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation (2002) 2.76
Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell (2007) 2.65
Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils. Neurosurgery (2004) 2.56
Adrenal GRK2 upregulation mediates sympathetic overdrive in heart failure. Nat Med (2007) 2.48
Gamma Knife surgery for incidental cerebral arteriovenous malformations. J Neurosurg (2014) 2.44
Endoscopic endonasal versus open transcranial resection of anterior midline skull base meningiomas. World Neurosurg (2011) 2.38
A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest (2003) 2.32
Animal models of heart failure: a scientific statement from the American Heart Association. Circ Res (2012) 2.31
Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J (2005) 2.29
Endovascular treatment of proximal and distal posterior inferior cerebellar artery aneurysms. J Neurosurg (2013) 2.23
G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure. Circ Res (2008) 2.22
Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation (2008) 2.17
Hyperphosphorylation of the cardiac ryanodine receptor at serine 2808 is not involved in cardiac dysfunction after myocardial infarction. Circ Res (2012) 2.16
C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation (2003) 2.16
Radiosurgery for Spetzler-Martin Grade III arteriovenous malformations. J Neurosurg (2014) 2.15
Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol (2003) 2.08
Subarachnoid hemorrhage due to isolated spinal artery aneurysm in four patients. AJNR Am J Neuroradiol (2005) 2.08
Cardiac-specific ablation of G-protein receptor kinase 2 redefines its roles in heart development and beta-adrenergic signaling. Circ Res (2006) 2.08
Identification of knowledge gaps in neurosurgery using a validated self-assessment examination: differences between general and spinal neurosurgeons. World Neurosurg (2012) 2.03
Aneurysmal subarachnoid hemorrhage in patients under 35-years-old: a single-center experience. Clin Neurol Neurosurg (2012) 2.01
Cerebrospinal fluid drainage and induced hypertension improve spinal cord perfusion after acute spinal cord injury in pigs. Neurosurgery (2015) 1.97
Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc Natl Acad Sci U S A (2008) 1.93
C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation (2012) 1.90
Negative impact of β-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension (2013) 1.83
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke (2011) 1.83
Gene therapy in heart failure. Circ Res (2008) 1.79
Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci U S A (2004) 1.76
Pharmacological- and gene therapy-based inhibition of protein kinase Calpha/beta enhances cardiac contractility and attenuates heart failure. Circulation (2006) 1.73
Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab (2012) 1.73
Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation (2007) 1.73
Radiosurgery for ruptured intracranial arteriovenous malformations. J Neurosurg (2014) 1.71
Standards for reporting randomized controlled trials in neurosurgery. J Neurosurg (2010) 1.71
Treatment of posterior circulation aneurysms with the pipeline embolization device. Neurosurgery (2013) 1.69
Long-term outcomes and prognostic factors in pediatric patients with severe traumatic brain injury and elevated intracranial pressure. J Neurosurg Pediatr (2008) 1.69
S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes. J Am Coll Cardiol (2011) 1.68
Perioperative management of patients undergoing transsphenoidal pituitary surgery. Anesth Analg (2005) 1.66
Influence of weekend versus weekday hospital admission on mortality following subarachnoid hemorrhage. Clinical article. J Neurosurg (2009) 1.66
β-Adrenergic regulation of cardiac progenitor cell death versus survival and proliferation. Circ Res (2012) 1.66
Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction. Circulation (2006) 1.64
Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage. Neurosurgery (2008) 1.63
Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg (2011) 1.62
Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res (2013) 1.62
β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing. Circ Res (2013) 1.59
Cardiac adenoviral S100A1 gene delivery rescues failing myocardium. J Clin Invest (2004) 1.58
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Impact of a standardized protocol and antibiotic-impregnated catheters on ventriculostomy infection rates in cerebrovascular patients. Neurosurgery (2010) 1.56
Endoscopic endonasal compared with anterior craniofacial and combined cranionasal resection of esthesioneuroblastomas. World Neurosurg (2012) 1.56
Characterization of perioperative seizures and epilepsy following aneurysmal subarachnoid hemorrhage. J Neurosurg (2003) 1.56
Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stress. Circulation (2008) 1.56
Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med (2011) 1.54
Stent-assisted coiling of intracranial aneurysms: predictors of complications, recanalization, and outcome in 508 cases. Stroke (2013) 1.54
Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes. World Neurosurg (2012) 1.53
Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms. Circ Res (2010) 1.52
Single-center experience with a dual microcatheter technique for the endovascular treatment of wide-necked aneurysms. J Neurosurg (2014) 1.52
Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction. Circulation (2012) 1.52
Direct evidence of intracrine angiotensin II signaling in neurons. Am J Physiol Cell Physiol (2014) 1.51
Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury. Crit Care Med (2011) 1.50
Dural arteriovenous fistulas: a review of the literature and a presentation of a single institution's experience. World Neurosurg (2012) 1.50
Moyamoya disorder in the United States. Neurosurgery (2012) 1.50
Radiographic evidence of cerebral hyperperfusion and reversal following angioplasty and stenting of intracranial carotid and middle cerebral artery stenosis: case report and review of the literature. J Neuroimaging (2009) 1.50
Anterior-to-posterior circulation approach for mechanical thrombectomy of an acutely occluded basilar artery using the penumbra aspiration system. World Neurosurg (2011) 1.48